G. Keenan

发表

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

D. Gladman, D. M. van der Heijde, M. Weisman, 2008, The Journal of rheumatology.

Infliximab (REMICADE) Therapy in the Treatment of Pediatric Crohn's Disease

R. Baldassano, K. Dewoody, G. Keenan, 2003, American Journal of Gastroenterology.

Osteoporosis and bone morbidity in cardiac transplant recipients.

D. Mancini, H. Eisen, P. Callegari, 1994, The American journal of medicine.

A retrospective analysis of low-field strength magnetic resonance imaging and the management of patients with rheumatoid arthritis

K. Hobbs, M. Schiff, G. Keenan, 2007, Current medical research and opinion.

A Prospective Open-label Trial of Remicade® in Patients With Severe Exacerbation of Crohn's Disease Requiring Hospitalization: A Comparison With Outcomes Previously Observed in Patients Receiving Intravenous Hydrocortisone

B. Korelitz, K. Mamun, G. Keenan, 2007, Journal of clinical gastroenterology.

Management of complications of glucocorticoid therapy.

G. Keenan, Gregory F. Keenan, 1997, Clinics in chest medicine.

The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year

D. Gladman, D. M. van der Heijde, M. Weisman, 2006, Annals of the rheumatic diseases.

Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease

S. Targan, E. Vasiliauskas, Huiying Yang, 2006, Journal of clinical gastroenterology.

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease.

O. Ramilo, A. Mejias, J. Burns, 2008, The Journal of pediatrics.

Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.

T. Schaible, A. Goldman, G. Keenan, 2002, The Journal of rheumatology.

Novel gastrointestinal tract manifestations in juvenile dermatomyositis.

P. Choyke, F. Miller, L. Rider, 1999, The Journal of pediatrics.

Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis.

B. Athreya, E. Giannini, G. Keenan, 1995, The Journal of rheumatology.

The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients.

E. Zackai, R. Markowitz, B. Clark, 1997, Genetic testing.

Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.

A. Levinson, S. Visvanathan, C. Wagner, 2007, The Journal of rheumatology.

Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis.

G. Keenan, N. Ilowite, B. Gottlieb, 1997, Pediatrics.

IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.

E. S. St. Clair, J. Smolen, S. Visvanathan, 2006, Arthritis and rheumatism.

Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis

G. Lichtenstein, C. Antoni, G. Keenan, 2004, The American Journal of Gastroenterology.

Outcome of pregnancy in patients receiving infliximab for the treatment of crohn's disease and rheumatoid arthritis

G. Lichtenstein, G. Keenan, J. Katz, 2003 .

Outcome of pregnancy in women receiving REMICADE® (Infliximab) for the treatment of Crohn's disease or rheumatoid arthritis

G. Lichtenstein, G. Keenan, Deirdre Healy, 2001 .

Arthritis associated with deletion of 22q11.2: more common than previously suspected.

E. Zackai, K. Sullivan, D. McDonald-McGinn, 1997, American journal of medical genetics.

FRI0069 Efficacy and safety of remicade (infliximab) plus arava (leflunomide) in rheumatoid arthritis (ra)

G. Keenan, S. Patel, A. Kraemer, 2001 .

Necrotising myositis: a surgical emergency that may have minimal changes in the skin

J. Huntley, G. Keenan, G. Smith, 2007, Emergency Medicine Journal.

Pyomyositis: Report of Three Patients and Review of the Literature

G. Keenan, B. Ostrov, İ. Akman, 1996, Clinical pediatrics.

Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome).

E. Zackai, K. Sullivan, B. Emanuel, 1997, Arthritis and rheumatism.

Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial*

J. Kremer, L. Moreland, P. Mease, 2005, Current medical research and opinion.

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

P. Lipsky, F. Breedveld, D. M. van der Heijde, 2004, Arthritis and rheumatism.

Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis.

C. Rosé, G. Keenan, B. Ostrov, 1997, The Journal of rheumatology.

Rheumatic symptoms associated with hypothyroidism in children.

B. Athreya, G. Keenan, B. Ostrov, 1993, The Journal of pediatrics.

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.

C. Wouters, R. Saurenmann, N. Wulffraat, 2007, Arthritis and rheumatism.

Sleep and Periodic Limb Movement in Sleep in Juvenile Fibromyalgia

R. Arens, G. Keenan, C. E. Tayag-Kier, 2000, Pediatrics.

Bilateral periorbital edema in systemic lupus erythematosus.

H. Schumacher, B. Freundlich, G. Keenan, 1993, The Journal of rheumatology.